enGene Holdings Inc. (ENGN) vs Entera Bio Ltd. (ENTX)
A side-by-side comparison of enGene Holdings Inc. and Entera Bio Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENGN
enGene Holdings Inc.
$1.83HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT
ENTX
Entera Bio Ltd.
$2.58HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
Total return — ENGN vs ENTX
growth of $100 · dividends reinvested · last 3yENGN -90.7% (-54.6%/yr)ENTX +282.5% (+56.4%/yr)ENTX compounded faster over this window
Log scale — wide-divergence pair
ENGN ENTX
ENGN vs ENTX: by the numbers
- •ENTX is the larger company ($127M vs $122M market cap).
- •Both run net losses; ENGN's is the smaller (0.00% vs -27235.71% net margin).
Metrics side by side
Valuation
| Metric | ENGN | ENTX |
|---|---|---|
| P/B ratio | 0.53 | 17.47 |
Profitability
| Metric | ENGN | ENTX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | -27450.00% |
| Net margin | 0.00% | -27235.71% |
| ROE | -2.13% | -234.42% |
| ROIC | -1.78% | -82.87% |
Growth (annualized)
| Metric | ENGN | ENTX |
|---|---|---|
| Total return CAGR (5Y) | N/A | -10.57% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.